Beth M. Faiman, PhD, MS, APN-BC, BMTCN, AOCN, FAAN, FAPO

Beth M. Faiman, PhD, MS, APN-BC, BMTCN, AOCN, FAAN, FAPO, is a nurse practitioner in the Multiple Myeloma Program at Cleveland Clinic in Ohio.

Articles

Patient-Reported Outcomes Show Benefits of Isatuximab On-Body Injector in Myeloma: With Sikander Ailawadhi, MD, and Beth Faiman, PhD, MS, APN-BC, BMTCN, AOCN, FAAN, FAPO

November 5th 2025

Ailawadhi and Faiman discuss the rationale for efforts to bring isatuximab on-body injectors into the clinic for patients with multiple myeloma.

Isatuximab-Based Triplet Delivered via On-Body System Shows Promise in RRMM: With Xavier Leleu, MD, PhD; and Beth Faiman, PhD, MSN, APN-BC

July 21st 2025

Xavier Leleu, MD, PhD, and Beth Faiman, PhD, MSN, APN-BC, BMTCN, AOCN, FAAN, FAPO, discuss key data from the phase 3 IRAKLIA study.

Holistic and Multidisciplinary Approaches to Multiple Myeloma Management

September 25th 2023

Closing out their program on multiple myeloma, expert panelists consider the role of holistic and multidisciplinary care when managing patients within the current paradigm.

Impact of Clinical Trials on the Management of Multiple Myeloma

September 25th 2023

Continuing its discussion on clinical trials in multiple myeloma, the panel emphasizes the impact that data may have on the real-world treatment landscape.

Importance of Clinical Trial Enrollment in Multiple Myeloma

September 18th 2023

Key opinion leaders in multiple myeloma management elucidate the value of clinical trials and share enthusiasm for improving enrollment when possible.

Multiple Myeloma: Regulatory Aspects of Treatment Development and Approval

September 18th 2023

A focused discussion on the regulatory aspects of drug testing and approval, globally, with respect to the setting of multiple myeloma management.

Educating Patients on Treatment Options for Multiple Myeloma

September 11th 2023

Expert panelists consider best methods in educating patients on their options for therapy following a diagnosis of multiple myeloma.

Treatment for Newly Diagnosed Multiple Myeloma: Addressing Disparities in Care

September 11th 2023

Comprehensive insight to disparities that may impact a patient’s access to therapy for multiple myeloma and how these may be overcome.

Treatment Considerations for Patients with Newly Diagnosed Multiple Myeloma

September 4th 2023

Panelists share a brief discussion on the current treatment armamentarium available to patients with newly diagnosed multiple myeloma.

Role of Diagnostic Testing in Patients with Multiple Myeloma

September 4th 2023

Experts in multiple myeloma management consider essential tests that aid in the diagnosis and treatment of newly presenting patients.

Educating on Multiple Myeloma: Patient and Physician Resources

August 21st 2023

Shared insight from key opinion leaders on educational resources made available to physicians and patients, respectively, regarding multiple myeloma management.

Multiple Myeloma: Challenges in Diagnosis and Role of Multidisciplinary Care

August 21st 2023

Opening its discussion on key unmet needs in multiple myeloma management, a panel of experts discuss key challenges faced when diagnosing patients with multiple myeloma and review the impact of having a multidisciplinary care team.